Thirteen patients with sickle cell disease reporting priapism recurrences at least twice weekly were randomized to receive sildenafil 50 mg or placebo daily , unassociated with sleep or sexual activity , for 8 weeks , followed by open-label use of this sildenafil regimen for an additional 8 weeks .